Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 safety, tolerability, and pharmacokinetic assessment of intravenous methylene blue at 1 mg/kg in healthy adults has completed, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Methemoglobinemia
• Methemoglobinemia

Drugs mentioned

• METHYLENE BLUE (METHYLENE BLUE)

Snippet

Sponsor: American Regent, Inc. | Conditions: Methemoglobinemia, Congenital Methemoglobinemia | Phase 1 | Status: COMPLETED | Results posted: 2025-06-05